Corporate Archives - ARC Group

Epsilogen completes £12.5 million Series B financing expansion

The Science of Business Returns

YELLOWSTONE BIOSCIENCES LAUNCHES AT ARC OXFORD

ARC supports the drive to revive Oxford-Cambridge high-tech growth plan

Oxford BioDynamics shortlisted for a strategic Government initiative to improve cancer immunotherapy.

Amgen secures first fast paced approval for life-saving new medicine

ARC OXFORD UNVEILS NEXT GENERATION ASCENT DEVELOPMENT

Accession Therapeutics raises £25m

Parexel named Best Contract Research Organisation

The UK has a life science literacy problem that goes beyond investors

Motherlabs Community Grows

Pioneering tomorrow’s science with inclusive lab spaces

you've seen 36 of 46 News

1
2
3
4